DOW JONES25,409.36-357.28 -1.39%
S&P 5002,954.22-24.54 -0.82%
NASDAQ8,567.37+0.89 0.01%

Antares Pharma Sees FY2019 Sales $120M vs $118.26M Est

Antares Pharma (NASDAQ:ATRS) . sees FY2019 sales of $120 million vs $118.26 million estimate.

Benzinga · 01/27/2020 12:08

Antares Pharma (NASDAQ:ATRS) . sees FY2019 sales of $120 million vs $118.26 million estimate.